Measuring lidocaine metabolite — monoethylglycinexylidide as a quantitative index of hepatic function in adults with chronic hepatitis and cirrhosis
- 1 January 1993
- journal article
- clinical trial
- Published by Elsevier in Journal of Hepatology
- Vol. 19 (1) , 140-147
- https://doi.org/10.1016/s0168-8278(05)80187-4
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Predictors of one-year pretransplant survival in patients with cirrhosisHepatology, 1991
- ASSESSMENT OF PRETRANSPLANT PROGNOSIS IN PATIENTS WITH CIRRHOSISTransplantation, 1991
- Assessment of lidocaine metabolite formation as a quantitative liver function test in childrenHepatology, 1990
- Assessment of liver function: Principles and practiceJournal of Gastroenterology and Hepatology, 1990
- Lidocaine Metabolite Formation as a Measure of Liver Function in Patients with CirrhosisTherapeutic Drug Monitoring, 1990
- LIGNOCAINE METABOLITE FORMATION AS A MEASURE OF PRE-TRANSPLANT LIVER FUNCTIONThe Lancet, 1989
- Drugs as Indicators of Hepatic FunctionHepatology, 1982
- Antipyrine, paracetamol, and lignocaine elimination in chronic liver disease.BMJ, 1977
- Transection of the oesophagus for bleeding oesophageal varicesBritish Journal of Surgery, 1973
- Lidocaine Pharmacokinetics in Advanced Heart Failure, Liver Disease, and Renal Failure in HumansAnnals of Internal Medicine, 1973